Expression of p21(WAF1) predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2615-2623

  Sarbia, Mario ^a   Stahl, Michael ^b   Zur Hausen, Axel ^a   Zimmermann, Katja ^a   Wang, Lihua ^a   Fink, Ulrich ^c   Heep, Hansjörg ^a   Dutkowski, Philipp ^d   Willers, Rainhart ^a   Müller, Wolfram ^a   Seeber, Siegfried ^b   Gabbert, Helmut E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P21; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ARTICLE; CANCER SURVIVAL; CELL CYCLE; DISEASE COURSE; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; ADULT; AGED; BIOSYNTHESIS; CANCER INVASION; CARCINOMA IN SITU; CELL CULTURE; CYTOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; MALE; METABOLISM; MIDDLE AGED; MUCOSA; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SURVIVAL; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031593374     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Müller, J. M., Erasmi, H., Stelzner, M., Zieren, U., and Pichlmaier, H. Surgical therapy of oesophageal carcinoma. Br. J. Surg., 77: 845-857, 1990.
2. Ilson, D. H., and Kelsen, D. P. Combined modality therapy in the treatment of esophageal cancer. Semin. Oncol., 21: 493-507, 1994.
3. Kelsen, D. P. Neoadjuvant therapy for esophageal cancer. Cancer J. Sci. Am., 3: 137-139, 1997.
4. Forastiere, A. A., Heitmiller, R. F., and Kleinberg, L. Multimodality therapy for esophageal cancer. Chest, 112 (Suppl.): 195S-200S, 1997.
5. Bosset, J. F., Gignoux, M., Triboulet, J. P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J. C., Pavy, J. J., Mercier, M., and Sahmoud, S. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med., 337: 161-167, 1997.
6. Roth, J. A., Lichter, A. S., Putnam, J. B., Jr., and Forastiere, A. A. Cancer of the esophagus. In: V. T. DeVita, Jr., S. Hellmann, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 776-817. Philadelphia: Lippincott, 1993.
7. Denham, J. W., Burmeister, B. H., Lamb, D. S., Spry, N. A., Joseph, D. J., Hamilton, C. S., Yeoh, E., O'Brien, P., and Walker, Q. J. Factors influencing outcome following radio-chemotherapy for oesophageal cancer. Radiother. Oncol., 40: 31-43, 1996.
8. Kitamura, M., Sumiyoshi, K. Sonoda, K., Kitamura, K., Tsutsui, S., Toh, Y., Kuwano, H., and Sugimachi, K. The clinical and histopathological contributing factors influencing the effectiveness of preoperative hyperthermo-chemo-radiotherapy for patients with esophageal cancer. Hepato-gastroenterol., 44: 175-180, 1997.
9. 1 arrest. Cell, 76: 1013-1024, 1994.
10. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 91: 5320-5334, 1994.
11. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M. P., and Wie, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387-400, 1995.
12. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
13. El-Deiry, W. S., Tokino, T., Veculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
14. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
15. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
16. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
17. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., and Wang, X. F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA, 92: 5545-5549, 1995.
18. 1 arrest in UV-irradiated human skin fibroblasts. Cancer Res., 57: 3390-3394, 1997.
19. DiGiuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, S. E., and Hruban, R. H. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol., 147: 884-888, 1995.
20. WAF1/CIP1 in human brain tumors Oncogene, 11: 2021-2028, 1995.
21. Wang, J., and Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (Washington DC), 273: 359-361, 1996.
22. Poluha, W., Poluha, D. K., Chang, B., Ciosbie, N. E., Schonhoff, C. M., Kilpatrick, D. L., and Ross, A. H. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol., 16: 1335-1341, 1996.
23. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., and Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
24. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.
25. Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res., 57: 4703-4706, 1997.
26. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
27. Zhang, W., Kornblau, S. M., Kobayashi, T., Gambel, A., Claxton, D., and Deisseroth, A. B. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin. Cancer Res., 1: 1051-1057, 1995.
28. Yang, G., Zhang, Z., Liao, J., Seril, D., Wang, L., Goldstein, S., and Yang, C. S. Immunohistochemical studies on WAF1p21, p16, pRB, and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int. J. Cancer, 72: 746-751, 1997.
29. Sobin, L. H., and Wittekind, C. (eds.). TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, 1997.
30. World Health Organization. Histological Typing of Oesophageal and Gastric Tumours, 2nd ed. Berlin: Springer-Verlag, 1990.
31. Stahl, M., Wilke, H., Fink, U., Stuschke, M., Walz, M. K., Siewert, J. R., Molls, M., Makoski, H. B., Breuer, N., Schmidt, U., Niebel, W., Sack, H., Eigler, F. W., and Seeber, S. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J. Clin. Oncol., 14: 829-837, 1996.
32. Sarbia, M., Bösing, N., Hildebrandt, B., Koldovsky, P., Gerharz, C. D., and Gabbert, H. E. Characterization of two newly established cell lines derived from squamous cell carcinomas of the esophagus. Anticancer Res., 17: 2185-2192, 1997.
33. El-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Topological control of p21WAF1/ CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
34. waf1 in human cutaneous squamous cell carcinomas. Am. J. Pathol., 149: 1139-1146, 1996.
35. CIP1/WAF1 protein accumulation in head-and-neck cancer. Int. J. Cancer, 74: 383-389, 1997.
36. Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma. Am. J. Pathol., 151: 461-470, 1997.
37. Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W. H., Felix, J., Jones, L. A., Hall, F. L., and Press, M. F. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am. J. Pathol., 150: 167-175, 1997.
38. Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F., and Barbareschi, M. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J. Pathol., 179: 248-253, 1996.
39. WAF1/CIP1 in normal, hyperplastic, and neoplastic uterine tissues. Hum. Pathol., 27: 60-66, 1997.
40. Zhang, H., Uedo, M., Ahmed, N., Nagano, T., and Ichihashi, M. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
41. Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA 90: 9026-9030, 1993.
42. Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., and Galloway, D. A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev., 11: 2090-2100, 1997.
43. CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol., 17: 4338-4345, 1997.
44. Diab, S. G., Yu, Y. Y., Hilsenbeck, S. G., Allred, D. C., and Elledge, R. M. WAF1/CIP1 protein expression in human breast cancer. Breast Cancer Res. Treat., 43: 99-103, 1997.
45. Ito, Y., Kobayashi, T., Takeda, T., Komoike, Y., Wakasugi, E., Tamaki, Y., Tsujimoto, M., Matsuura, N., and Monden, M. Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. Br. J. Cancer, 74: 1269-1274, 1996.
46. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., McDonnell, T. J., Steck, P. A., Levin, V. A., and Yung, W. K. A. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J. Natl. Cancer Inst., 89: 1036-1044, 1997.